Page last updated: 2024-08-23

daunorubicin and mometasone furoate

daunorubicin has been researched along with mometasone furoate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Edwards, BS; Khawaja, HM; Larson, RS; Lovato, DM; Oprea, TI; Sklar, LA; Steele, ID; Winter, SS; Young, SM	1

Other Studies

1 other study(ies) available for daunorubicin and mometasone furoate

Article	Year
High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent. Journal of biomolecular screening, 2008, Volume: 13, Issue:3 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Assay; Carbocyanines; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Jurkat Cells; Mometasone Furoate; Pregnadienediols; Up-Regulation	2008

Article

Year

High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent.

Journal of biomolecular screening, 2008, Volume: 13, Issue:3

Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Assay; Carbocyanines; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Jurkat Cells; Mometasone Furoate; Pregnadienediols; Up-Regulation

2008